Phosphatidylserine nanobubbles: A macrophage-targeted ultrasound contrast agent – promising approach for the early detection of acute cardiac rejection
International Immunopharmacology · 2026-06 · 178 · 116589
DOI: 10.1016/j.intimp.2026.116589 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2026-06. Verfasst von Xintong Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Ultrasound Molecular Imaging Joint Labor…. Hauptthemen laut MEDLINE: Phosphatidylserines, Nanostructures, Contrast Media, Ultrasonography. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND Acute rejection (AR) continues to be a leading cause of mortality following heart transplantation. Endomyocardial biopsy, the current gold standard for monitoring, is limited by its invasiveness. Macrophage infiltration into the myocardial interstitium is an early hallmark of AR, targeting these specific cells offers a novel strategy for the accurate and stable noninvasive detection of rejection signals. To address this unmet clinical need, we developed a macrophage-targeted ultrasound contrast agent - phosphatidylserine nanobubbles (PS-NBs). METHODS PS-NBs were fabricated and their targeting ability toward macrophages was evaluated. Heterotopic heart transplantation models were established, and PS-NBs were injected for ultrasound molecular imaging. Signal intensity (SI) was compared between allografts and isografts. Imaging results were validated via H&E and CD68 immunohistochemical staining. RESULTS PS-NBs can effectively target macrophages. In allografts, PS-NBs exhibited significantly higher SI compared to control NBs. The SI of PS-NBs in the allograft group at seven days post-transplantation was stronger than that at three days, and significantly exceeded the SI observed in the isograft group. Crucially, a strong positive correlation was observed between PS-NB SI and macrophage infiltration density. CONCLUSION By specifically targeting macrophages that infiltrate in the myocardial interstitium, PS-NBs enable the highly accurate, stable, and noninvasive early detection of AR via ultrasound molecular imaging. This innovative strategy represents a key methodological improvement over current detection. Importantly, owing to their high in vivo biocompatibility, PS-NBs demonstrate considerable promise for future clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China; Ultrasound Molecular Imaging Joint Laboratory of Heilongjiang Province (International Cooperation), Harbin 150…
- Laboratory Animal Center, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
- Department of Ultrasound, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
- Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Electronic address: ultrazw@sina.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, X., Chen, J., Sun, P., Zhao, C., Zhang, X., Zhao, P., Liu, J., Shan, J., Yu, D., Yin, L., Wang, Z., Zhang, W., & Leng, X. (2026). Phosphatidylserine nanobubbles: A macrophage-targeted ultrasound contrast agent – promising approach for the early detection of acute cardiac rejection. International Immunopharmacology, 178, 116589. https://doi.org/10.1016/j.intimp.2026.116589
Vancouver
Li X, Chen J, Sun P, Zhao C, Zhang X, Zhao P, et al. Phosphatidylserine nanobubbles: A macrophage-targeted ultrasound contrast agent – promising approach for the early detection of acute cardiac rejection. International Immunopharmacology. 2026;178:116589. doi:10.1016/j.intimp.2026.116589
BibTeX
@article{Li2026,
author = {Li, Xintong and Chen, Jianfeng and Sun, Ping and Zhao, Chen and Zhang, Xin and Zhao, Peng and Liu, Jinhong and Shan, Jiaxin and Yu, Dandan and Yin, Li and Wang, Zhuo and Zhang, Wei and Leng, Xiaoping},
title = {Phosphatidylserine nanobubbles: A macrophage-targeted ultrasound contrast agent – promising approach for the early detection of acute cardiac rejection},
journal = {International Immunopharmacology},
year = {2026},
volume = {178},
pages = {116589},
doi = {10.1016/j.intimp.2026.116589}
}
EUVIMED